L01XE Protein kinase inhibitors

No definition available.

Endpoint definition

FinnGen phenotype data
diagram bullet diagram downward connector

Filter registries KELA purch., KELA reimb.

Medicine purchases: ATC L01XE
Medicine purchases: ATC: other data required >3 instances required

Check pre-conditions None

Include endpoints None

Check conditions None

Apply sex-specific rule None

diagram downward connector RX_L01XE

Extra metadata

First used in FinnGen datafreeze DF3

Summary Statistics

Key figures

All Female Male
Number of individuals 1041 528 513
Unadjusted prevalence (%) 0.40 0.36 0.45
Mean age at first event (years) 65.32 63.61 67.08

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Correlations

Index endpoint: RX_L01XE – L01XE Protein kinase inhibitors
GWS hits:

Survival analyses between endpoints

Plot

before L01XE Protein kinase inhibitors
after L01XE Protein kinase inhibitors

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after L01XE Protein kinase inhibitors